Economics methods in the Clinical Outcomes Utilizing percutaneous coronary Revascularization and Aggressive Guideline-driven drug Evaluation (COURAGE) trial
Open Access
- 30 June 2006
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 151 (6) , 1180-1185
- https://doi.org/10.1016/j.ahj.2005.07.035
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Country specific cost comparisons from multinational clinical trials using empirical Bayesian shrinkage estimation: the Canadian ASSENT-3 economic analysisHealth Economics, 2005
- Long-term cost-effectiveness of clopidogrel given for up to one year in patients with acute coronary syndromes without ST-segment elevationJournal of the American College of Cardiology, 2005
- Assessing generalisability by location in trial‐based cost‐effectiveness analysis: the use of multilevel modelsHealth Economics, 2004
- 889-3 Estimating life-years lost due to atherothrombotic events: Flexible survival functions for use in disease modelingJournal of the American College of Cardiology, 2004
- Cost-Effectiveness of a Conservative, Ischemia-Guided Management Strategy After Non–Q-Wave Myocardial InfarctionCirculation, 2002
- Cost prediction models for the comparison of two groupsHealth Economics, 2001
- Multiple Imputation after 18+ YearsJournal of the American Statistical Association, 1996
- Rapid Estimation of Hospital Charges in Patients with LeukemiaMedical Care, 1989
- Rapid Estimation of Hospitalization Charges From a Brief Medical Record ReviewMedical Care, 1986
- The Decomposition of Time-Varying Hazard into Phases, Each Incorporating a Separate Stream of Concomitant InformationJournal of the American Statistical Association, 1986